First Header Logo Second Header Logo

The impact of initial tumor bulk in DLBCL treated with DA-EPOCH-R vs. R-CHOP: a secondary analysis of alliance/CALGB 50303.

Lanier CM, Razavian NB, Smith S, D'Agostino RB, Hughes RT. The impact of initial tumor bulk in DLBCL treated with DA-EPOCH-R vs. R-CHOP: a secondary analysis of alliance/CALGB 50303. Leuk Lymphoma. 2024 Dec; 65(14):2199-2206.

View in: PubMed